All Stories

  1. SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans

    Article • Diabetes, July 2021, American Diabetes Association

    Yusuke Moritoh

  2. SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Yusuke Moritoh